S&P 500   3,197.52 (+1.34%)
DOW   26,642.59 (+2.13%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   3,197.52 (+1.34%)
DOW   26,642.59 (+2.13%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   3,197.52 (+1.34%)
DOW   26,642.59 (+2.13%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   3,197.52 (+1.34%)
DOW   26,642.59 (+2.13%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
Log in

NASDAQ:UTMDUtah Medical Products Stock Price, Forecast & News

$82.40
-0.48 (-0.58 %)
(As of 07/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$80.80
Now: $82.40
$83.40
50-Day Range
$82.78
MA: $94.29
$106.28
52-Week Range
$75.33
Now: $82.40
$112.26
Volume23,500 shs
Average Volume15,599 shs
Market Capitalization$300.10 million
P/E Ratio20.91
Dividend Yield1.36%
Beta0.39
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It also provides umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; MYELO-NATE, a lumbar sampling kit; and HEMO-NATE, a disposable filter. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars and cannulae; Femcare laparoscopic instruments and accessories; and EPITOME, an electrosurgical scalpel. Further, it provides FILSHIE CLIP system, a female surgical contraception; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization; LIBERTY system to treat and control urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other suspected abnormalities of the uterus; and LUMIN to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It markets its products to neonatal intensive care unit, labor and delivery department, women's health center in hospitals, outpatient clinics, and physician's offices. The company sells its products through customer service and sales force, independent consultants, and independent manufacturer representatives. Utah Medical Products, Inc. was founded in 1978 and is headquartered in Midvale, Utah.
Read More
Utah Medical Products logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.8Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.93 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:UTMD
CUSIP91748810
Phone801-566-1200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$46.90 million
Cash Flow$5.62 per share
Book Value$27.17 per share

Profitability

Net Income$14.73 million

Miscellaneous

Employees173
Market Cap$300.10 million
Next Earnings Date8/4/2020 (Estimated)
OptionableNot Optionable

Receive UTMD News and Ratings via Email

Sign-up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter.

Utah Medical Products (NASDAQ:UTMD) Frequently Asked Questions

How has Utah Medical Products' stock been impacted by COVID-19 (Coronavirus)?

Utah Medical Products' stock was trading at $88.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, UTMD shares have decreased by 6.9% and is now trading at $82.40. View which stocks have been most impacted by Coronavirus.

When is Utah Medical Products' next earnings date?

Utah Medical Products is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Utah Medical Products.

How were Utah Medical Products' earnings last quarter?

Utah Medical Products, Inc. (NASDAQ:UTMD) released its quarterly earnings data on Thursday, April, 23rd. The medical instruments supplier reported $0.84 EPS for the quarter. The medical instruments supplier earned $10.90 million during the quarter. Utah Medical Products had a net margin of 31.29% and a return on equity of 14.72%. View Utah Medical Products' earnings history.

How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?

Utah Medical Products declared a quarterly dividend on Friday, May 8th. Investors of record on Wednesday, June 17th will be paid a dividend of $0.28 per share on Friday, July 3rd. This represents a $1.12 annualized dividend and a dividend yield of 1.36%. The ex-dividend date is Tuesday, June 16th. View Utah Medical Products' dividend history.

Has Utah Medical Products been receiving favorable news coverage?

News articles about UTMD stock have been trending somewhat negative this week, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Utah Medical Products earned a news impact score of -1.5 on InfoTrie's scale. They also assigned news articles about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about Utah Medical Products.

Are investors shorting Utah Medical Products?

Utah Medical Products saw a increase in short interest in June. As of June 15th, there was short interest totaling 97,900 shares, an increase of 20.7% from the May 31st total of 81,100 shares. Based on an average daily trading volume, of 15,200 shares, the short-interest ratio is currently 6.4 days. Approximately 2.9% of the company's shares are sold short. View Utah Medical Products' Current Options Chain.

Who are some of Utah Medical Products' key competitors?

What other stocks do shareholders of Utah Medical Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include Altria Group (MO), Simon Property Group (SPG), Trupanion (TRUP), UnitedHealth Group (UNH), AbbVie (ABBV), Avery Dennison (AVY), Franklin Resources (BEN), Carnival (CCL), Quest Diagnostics (DGX) and Walt Disney (DIS).

Who are Utah Medical Products' key executives?

Utah Medical Products' management team includes the following people:
  • Mr. Kevin L. Cornwell, Chairman, CEO, Pres & Sec. (Age 72)
  • Mr. Brian L. Koopman, Principal Financial Officer & Controller

What is Utah Medical Products' stock symbol?

Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."

How do I buy shares of Utah Medical Products?

Shares of UTMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Utah Medical Products' stock price today?

One share of UTMD stock can currently be purchased for approximately $82.40.

How big of a company is Utah Medical Products?

Utah Medical Products has a market capitalization of $300.10 million and generates $46.90 million in revenue each year. Utah Medical Products employs 173 workers across the globe.

What is Utah Medical Products' official website?

The official website for Utah Medical Products is www.utahmed.com.

How can I contact Utah Medical Products?

Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The medical instruments supplier can be reached via phone at 801-566-1200.

This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.